0B68 Jabbour, Pascal M. - Thomas Jefferson University - Thomas Jefferson University
Pascal M. Jabbour, MD

Pascal M. Jabbour, MD

Contact Dr. Jabbour

909 Walnut Street
2nd Floor
Philadelphia, Pennsylvania 19107

(215) 955-7000
(215) 503-7038 fax

Most Recent Peer-reviewed Publications

  1. Intra-arterial Chemotherapy for Retinoblastoma in 70 Eyes. Outcomes Based on the International Classification of Retinoblastoma
  2. Endovascular management of cerebral vasospasm following aneurysm rupture: Outcomes and predictors in 116 patients
  3. Flow diversion for complex middle cerebral artery aneurysms
  4. Stereotactic radiosurgery with neoadjuvant embolization of larger arteriovenous malformations: An institutional experience
  5. The use of adenosine in the treatment of a high-flow vein of Galen malformation in an adult
  6. Treatment of aneurysmal subarachnoid hemorrhage in young patients
  7. Final results of the multicenter, prospective Axium MicroFX for Endovascular Repair of IntraCranial Aneurysm Study (AMERICA)
  8. Aspirin for prevention of subarachnoid hemorrhage: The stage is set for a randomized controlled trial
  9. Aspirin for prophylaxis against cerebral aneury 111C sm rupture
  10. Endovascular stroke intervention in young patients with large vessel occlusions
  11. Short-term outcome for saccular cerebral aneurysms treated with the Orbit Galaxy Detachable Coil System
  12. Endovascular Management of Cerebral Aneurysm: Review of the Literature
  13. Treatment of recurrent intracranial aneurysms with the Pipeline Embolization Device
  14. Endovascular treatment of carotid cavernous aneurysms: Complications, outcomes and comparison of interventional strategies
  15. Extending the indications of flow diversion to small, unruptured, saccular aneurysms of the anterior circulation
  16. Aneurysm geometry in predicting the risk of rupture. A review of the literature
  17. Endovascular treatment of fusiform cerebral aneurysms with the Pipeline Embolization Device
  18. Coiling of large and giant aneurysms: Complications and long-term results of 334 cases
  19. Single-agent, minimal dose, minimal exposure intraarterial chemotherapy for retinoblastoma in a 4-month-old infant
  20. The pipeline embolization devi What have we learned?
0